Surgery Partners insider files Form 144 for 85,785-share sale on NASDAQ

Rhea-AI Filing Summary

Surgery Partners, Inc. (SGRY) Form 144 reports a proposed sale of 85,785 common shares through UBS Financial Services with an aggregate market value of $1,873,875, with an approximate sale date of 09/17/2025 on NASDAQ. The shares were acquired on 09/17/2025 by equity compensation from Surgery Partners, Inc., with payment described as an equity option exercise. The filing also discloses multiple recent open-market sales by Wayne DeVeydt totaling 392,579 shares between 08/21/2025 and 09/16/2025 generating aggregate gross proceeds reported in the table. The signee represents no undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Insider proposes to sell newly exercised shares; recent substantial but not company-changing insider dispositions were reported.

The Form 144 shows an executive-level or other insider conversion of equity compensation and a proposed sale of 85,785 shares via UBS on 09/17/2025 valued at $1,873,875. The filing is procedural under Rule 144 and documents an equity option exercise as the acquisition method. The historical sales table lists multiple market disposals by Wayne DeVeydt totaling 392,579 shares over several dates in Aug–Sep 2025, with reported gross proceeds for each trade. Relative to the reported 128,209,410 shares outstanding, these transactions represent a small fraction of the float, and the filing contains standard signer representations about lack of undisclosed material information.

Corporate Governance Expert

TL;DR: Disclosure aligns with Rule 144 procedures; no governance red flags are evident within this filing alone.

The document discloses the required specifics for a Rule 144 notice: broker, share count, market value, acquisition method, and past three-month sales by the named person. The acquisition is recorded as equity compensation with an option exercise on the same date as the proposed sale, and the seller attests to absence of material non-public information. There are no statements here about trading plans or 10b5-1 adoption dates, and no indication of regulatory, litigation, or operational developments in this filing.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	85785	1873875	128209410	09/17/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
common	09/17/2025	equity compensation	Surgery Partners, Inc.			85785	09/17/2025	equity option exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	08/21/2025	100000	2299011
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	08/26/2025	25000	572717
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	08/27/2025	11865	271756
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/02/2025	25000	562150
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/03/2025	25000	560251
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/04/2025	25000	562756
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/05/2025	25000	563682
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/08/2025	2014	45207
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/11/2025	100000	2200741
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/12/2025	28700	628929
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/16/2025	25000	541518

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for Surgery Partners (SGRY) report?

The form reports a proposed sale of 85,785 common shares through UBS with aggregate market value $1,873,875 and an approximate sale date of 09/17/2025.

How were the shares to be sold acquired according to the filing?

The shares were acquired on 09/17/2025 via equity compensation from Surgery Partners, Inc., with payment described as an equity option exercise.

Who sold shares in the past three months and how many?

Wayne DeVeydt sold a series of common shares between 08/21/2025 and 09/16/2025 totaling 392,579 shares, with gross proceeds listed per sale.

Which broker is handling the proposed sale?

UBS Financial Services Inc., 1000 Harbor Blvd, 3rd Floor, Weehawken, NJ, is named as the broker for the proposed sale.

Does the filing indicate any undisclosed material information about Surgery Partners?

The signer represents they do not know of any material adverse information about the issuer that has not been publicly disclosed.